Spectral Medical Inc.
EDTXF
$0.95
$0.010.74%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.77% | 4.90% | 31.23% | 29.28% | 22.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.77% | 4.90% | 31.23% | 29.28% | 22.06% |
| Cost of Revenue | -23.21% | -31.69% | -15.34% | -8.85% | 24.04% |
| Gross Profit | 136.59% | 90.92% | 155.11% | 130.80% | 17.89% |
| SG&A Expenses | -9.86% | -0.39% | -0.72% | -0.84% | 9.26% |
| Depreciation & Amortization | -73.01% | -76.03% | -78.33% | -78.74% | 111.17% |
| Other Operating Expenses | -0.21% | 38.79% | 11.26% | -7.40% | -10.25% |
| Total Operating Expenses | -13.64% | -7.19% | -5.90% | -5.66% | 12.43% |
| Operating Income | 20.16% | 9.48% | 11.88% | 10.96% | -11.01% |
| Income Before Tax | -61.41% | -200.93% | -62.96% | -10.67% | -24.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.41% | -200.93% | -62.96% | -10.67% | -24.10% |
| Earnings from Discontinued Operations | 56.00% | 58.82% | 79.42% | 95.87% | 94.10% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.38% | -200.81% | -62.77% | -9.74% | -23.38% |
| EBIT | 20.16% | 9.48% | 11.88% | 10.96% | -11.01% |
| EBITDA | 20.38% | 9.55% | 12.10% | 11.09% | -11.01% |
| EPS Basic | -58.61% | -194.09% | -59.30% | -8.03% | -21.77% |
| Normalized Basic EPS | -46.03% | -175.59% | -72.25% | -13.09% | -26.85% |
| EPS Diluted | -58.61% | -194.09% | -59.30% | -8.03% | -21.77% |
| Normalized Diluted EPS | -46.03% | -175.59% | -72.25% | -13.09% | -26.85% |
| Average Basic Shares Outstanding | 2.37% | 2.10% | 1.82% | 1.63% | 1.33% |
| Average Diluted Shares Outstanding | 2.37% | 2.10% | 1.82% | 1.63% | 1.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |